ProVu Video Stylet With Versus Without the Fekry Airway
Comparison of Intubation Time and Performance Between the ProVu Video Stylet With Versus Without the Fekry Airway in Adults With Normal Airway: A Single-Blinded Randomized Controlled Trial
1 other identifier
interventional
130
1 country
1
Brief Summary
This study aimed to compare assisted intubation using the ProVu video stylet device passing through Fekry airway versus intubation without the use of Fekry airway . The investigators hypothesized that endotracheal intubation assisted by ProVu video stylet using the Fekry airway as a conduit for intubation would improve the glottic visualization and the higher first attempt success rate when compared to endotracheal intubation assisted by ProVu video stylet without using the Fekry airway.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2026
CompletedFirst Posted
Study publicly available on registry
May 6, 2026
CompletedStudy Start
First participant enrolled
May 10, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2026
Study Completion
Last participant's last visit for all outcomes
October 10, 2026
May 6, 2026
May 1, 2026
4 months
April 24, 2026
May 1, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Time to successful intubation
It is defined as time in seconds elapsing from touching assimply of ProVu video stylet to insisors (C group)or to Fekry Airway ( F group) till connecting the endotracheal tube to ventlatory circuate after removal of assimply
up to 24 weeks
Study Arms (2)
Group C (n=55): Intubation using the ProVu video stylet without the Fekry Airway.
OTHERThe ProVu™ video stylet's novelty is a manoeuvrable tip controlled by a bidirectional wheel enabling flexion and retroflexion both of the stylet and tracheal tube with a 95° range of movement. It requires a specific tracheal tube where a softer polyvinyl chloride material is utilised in its distal section underneath the cuff enabling the tip to be flexed. Both the tracheal tube and video stylet are single-use and come with a range of high-resolution reusable video displays for a shared view of the airway
Group F (n =55): endotracheal Intubation assisted by the ProVu video stylet and using Fekry Airway
OTHERThe ProVu™ video stylet's novelty is a manoeuvrable tip controlled by a bidirectional wheel enabling flexion and retroflexion both of the stylet and tracheal tube with a 95° range of movement. It requires a specific tracheal tube where a softer polyvinyl chloride material is utilised in its distal section underneath the cuff enabling the tip to be flexed. Both the tracheal tube and video stylet are single-use and come with a range of high-resolution reusable video displays for a shared view of the airway Size10 of the FEKRY airway will be selected.
Interventions
Group C (n=55): Intubation using the ProVu video stylet without the Fekry Airway.
Group F (n =55): endotracheal Intubation assisted by the ProVu video stylet and using Fekry Airway
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists (ASA) physical status I, II.
- Patients scheduled for elective surgery requiring general anesthesia and orotracheal intubation of less than 2 hours duration .
- Ganzouri Airway score \<3.
You may not qualify if:
- Patient with Active cardiac condition.
- Patient with airway congenital anomaly.
- Mallampati score III or IV.
- Body mass index (BMI) \> 35 kg/m² (obesity).
- Limited cervical spine mobility.
- History of difficult intubation, upper airway surgery, or trauma.
- Facial or oropharyngeal deformities.
- Allergy or contraindication to study medications.
- Refusal to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of Medicine-Cairo University
Cairo, 11562, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Reham Ali Abdelrahman
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Anesthesia, Surgical ICU and Pain Management-Faculty of Medicine-Cairo University
Study Record Dates
First Submitted
April 24, 2026
First Posted
May 6, 2026
Study Start (Estimated)
May 10, 2026
Primary Completion (Estimated)
September 10, 2026
Study Completion (Estimated)
October 10, 2026
Last Updated
May 6, 2026
Record last verified: 2026-05